A patient at risk of suicide
56 results
1 - 56
Newer generation antidepressants for depressive disorders in children and adolescents- Pharmacological interventions for self‐harm in adults
- Pharmacological interventions for self‐harm in adults
- Lithium for maintenance treatment of mood disorders
- Psychosocial and pharmacological treatments for deliberate self harm: Cochrane systematic review
- Psychosocial interventions for preventing and treating depression in dialysis patients
- Antidepressants for anorexia nervosa
- New generation antidepressants for depression in children and adolescents: a network meta‐analysis
- Lithium versus antidepressants in the long‐term treatment of unipolar affective disorder
- Psychosocial interventions for self‐harm in adults
- Interventions for preventing injuries in problem drinkers
- Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality
- Magnetic seizure therapy for treatment‐resistant depression
- Interventions for self‐harm in children and adolescents
- Amitriptyline for depression
- Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus
- Antidepressants for treating depression in adults with end‐stage kidney disease treated with dialysis
- Interventions for self‐harm in children and adolescents
- Psychosocial interventions for self‐harm in adults
- Antidepressants versus placebo for generalised anxiety disorder (GAD)
- Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD): Cochrane systematic review
- Haloperidol alone or in combination for acute mania
- Selective serotonin reuptake inhibitors for fibromyalgia syndrome
- Interventions for smoking cessation and reduction in individuals with schizophrenia
- Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury
- Psychological therapies for people with borderline personality disorder
- Family intervention for schizophrenia
- Interferon alpha for chronic hepatitis D
- Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults
- Baclofen for alcohol use disorder
- Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries
- Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults
- Couple and family therapies for post‐traumatic stress disorder (PTSD)
- Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
- Mirtazapine for fibromyalgia in adults
- Psychological therapies for treatment‐resistant depression in adults
- Intensive case management for severe mental illness
- Neuromodulators for pain management in rheumatoid arthritis
- Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses
- Electroconvulsive therapy for schizophrenia: Cochrane systematic review
- Antiepileptic drugs for chronic non‐cancer pain in children and adolescents